On Wednesday, Shares of Peabody Energy Corporation (NYSE:BTU), gained 7.84% to $1.10.
Peabody Energy stated second quarter 2015 revenues of $1.34 billion. Adjusted EBITDA totaled $87.0 million, which comprises $21.2 million in restructuring charges related to reductions in corporate and regional staff and Australian Mining Operations. Diluted Loss Per Share from Ongoing Operations totaled $(3.71), counting a $(3.06) per share impact related to asset impairments. Adjusted Diluted EPS totaled $(0.65), counting a $(0.07) per share impact related to restructuring activities.
“Peabody accelerated a number of initiatives in the second quarter to reduce operating costs, create a leaner organization and optimize our portfolio,” said Peabody Energy President and Chief Executive Officer Glenn Kellow. “As we manage through extended low-cycle market conditions, Peabody is taking aggressive actions on multiple fronts to preserve and enhance long-term value.”
Peabody Energy Corporation offers mining of coal. The company operates through Western U.S. Mining, Midwestern U.S. Mining, Australian Mining, Trading and Brokerage, and Corporate and Other segments.
Shares of Abbott Laboratories (NYSE:ABT), declined -0.06% to $50.48, during its last trading session.
Abbott declared financial results for the second quarter ended June 30, 2015.
Second-quarter worldwide sales of $5.2 billion raised 10.8 percent on an operational basis and 2.2 percent on a stated basis. Worldwide sales raised 6.4 percent not taking into account the impact of 2014 acquisitions and foreign exchange.
Diluted EPS from ongoing operations on both an adjusted and GAAP basis was $0.52 in the second quarter.
Abbott’s full-year 2015 adjusted EPS guidance range for ongoing operations remains unchanged at $2.10 to $2.20. Projected full-year 2015 EPS for ongoing operations under GAAP is $1.50 to $1.60.
Second-quarter gross margin ratio was ahead of expectations, primarily driven by continued improvements in Diagnostics and Nutrition.
In the second quarter, Abbott received European approval for Absorb GT1TM, which combines the world’s first fully dissolving stent with a next-generation delivery catheter; accomplished submissions for regulatory approval of Absorb in Japan and the U.S.; presented for U.S. regulatory approval of its FreeStyle Libre Pro Flash Glucose Monitoring System for professional use; and received U.S. FDA clearance for a first-of-its-kind blood test for its i-STAT handheld system to aid in detecting early pregnancy in emergency situations.
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon.
Finally, RingCentral Inc (NYSE:RNG), ended its last trade with 0.26% gain, and closed at $19.44.
RingCentral, declared that Clyde Hosein, Executive Vice President and Chief Financial Officer, will be presenting at:
- Oppenheimer Technology, Internet & Communications Conference in Boston, MA on Tuesday, August 11, 2015 at 10:05 a.m. Pacific Time or 1:05 p.m. Eastern Time.
- Canaccord Genuity Growth Conference in Boston, MA on Wednesday, August 12, 2015 at 2:00 p.m. Pacific Time or 5:00 p.m. Eastern Time.
RingCentral, Inc. provides software-as-a-service solutions for business communications primarily in the United States. The company’s products comprise RingCentral Office, a multi-location, multi-user, enterprise-grade communications solution that enables employees to communicate through voice, text, HD video and Web conferencing, and fax on devices, counting smartphones, tablets, PCs, and desk phones for businesses that require a communications solution; RingCentral Professional, an inbound call routing service with text and fax capabilities primarily for smaller businesses; and RingCentral Fax solution that provides Internet fax capabilities, which allow businesses to send and receive fax documents without the need for a fax machine.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
